{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:05Z","timestamp":1787841305060,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:00:00Z","timestamp":1558742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective\/background:<\/jats:title>\n                    <jats:p>\n                      Sickle cell disease (SCD) is a chronic inflammatory condition caused by a point mutation in the\n                      <jats:italic toggle=\"yes\">HBB<\/jats:italic>\n                      gene. Here we characterized the clinical presentation of SCD in a population from Amazonas State in northern Brazil, in order to evaluate whether the higher Amerindian ancestry observed in this relatively isolated geographic region would influence the clinical presentation of SCD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional study characterizing the clinical presentation of SCD patients registered at HEMOAM, Amazon, Brazil. Data were obtained using a structured questionnaire, and by a review of the medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 236 SCD patients listed in the historical records, 122 were included in this study. The median age was 15 years, with a male to female ratio of 52:70. The population was characterized by a high level of socioeconomic vulnerability, with only 2.1% presenting a family income above five minimum wages. Homozygous HbS (SS) was the most prevalent form of SCD (89.7%), and the diagnosis of SCD was performed in the context of complications in 92.3% of patients. The median frequency of vaso-occlusive crisis in the past 12 months was 2 (0-10). Using a validated clinical severity score based on clinical and laboratory data, no significant difference could be observed when compared to other populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our results represent the first comprehensive characterization of epidemiological, laboratorial, and clinical data of SCD in the region of the Brazilian Amazon. Despite the higher contribution of Amerindian ancestry previously demonstrated in this region, the main clinical characteristics of SCD seem similar to those reported in other populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:37:38Z","timestamp":1559043458000},"page":"204-210","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiological, clinical, and severity characterization of sickle cell disease in a population from the Brazilian Amazon"],"prefix":"10.4103","volume":"12","author":[{"given":"Purim","family":"Cesar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Dhyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Augusto","family":"Schwade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyana","family":"Acordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia Xerez","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejane","family":"Nina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich V. De","family":"Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Fraiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.hemonc.2019.04.002_b0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hemonc.2019.04.002_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.hemonc.2019.04.002_b0015","doi-asserted-by":"crossref","first-page":"17822","DOI":"10.1038\/srep17822","article-title":"Role of innate immunity-triggered pathways in the pathogenesis of sickle cell disease: A meta-analysis of gene expression studies","volume":"5","author":"Hounkpe","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.hemonc.2019.04.002_b0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.hemonc.2019.04.002_b0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011783","article-title":"The natural history of sickle cell disease","volume":"3","author":"Serjeant","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.hemonc.2019.04.002_b0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1353\/jwh.1999.0005","article-title":"The slave trade: the story of the Atlantic slave trade, 1440\u20131870 (review)","volume":"10","author":"Elbl","year":"1999","journal-title":"J World Hist"},{"key":"10.1016\/j.hemonc.2019.04.002_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1590\/S1413-81232005000200014","article-title":"Educa\u00e7\u00e3o para a gen\u00e9tica em sa\u00fade p\u00fablica : um estudo de caso sobre a anemia falciforme","volume":"10","author":"Diniz","year":"2003","journal-title":"Ci\u00eancias e Sa\u00fade Coletiva"},{"key":"10.1016\/j.hemonc.2019.04.002_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152573","article-title":"Male lineages in Brazil: Intercontinental admixture and stratification of the European background","volume":"11","author":"Resque","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hemonc.2019.04.002_b0045","first-page":"204","article-title":"A doen\u00e7a falciforme no Brasil","author":"Can\u00e7ado","year":"2007","journal-title":"Rev Bras Hematol Hemoter."},{"key":"10.1016\/j.hemonc.2019.04.002_b0050","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1182\/blood-2011-06-361915","article-title":"Extensive admixture in Brazilian sickle cell patients: Implications for the mapping of genetic modifiers","volume":"118","author":"Da Silva","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.hemonc.2019.04.002_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083926","article-title":"Association of genetic variants with self-assessed color categories in Brazilians","volume":"9","author":"Durso","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hemonc.2019.04.002_b0060","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2007-04-084921","article-title":"A network model to predict the risk of death in sickle cell disease","volume":"110","author":"Sebastiani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hemonc.2019.04.002_b0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/ehm.10.44","article-title":"Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment","volume":"3","author":"Fertrin","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.hemonc.2019.04.002_b0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2013.01.035","article-title":"Identifying recent adaptations in large-scale genomic data","volume":"152","author":"Grossman","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.hemonc.2019.04.002_b0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1590\/S0100-879X2009005000026","article-title":"DNA tests probe the genomic ancestry of Brazilians","volume":"42","author":"Pena","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.hemonc.2019.04.002_b0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jped.2015.01.002","article-title":"Newborn screening for sickle cell disease: Necessary but not sufficient","volume":"91","author":"Wang","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.hemonc.2019.04.002_b0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.5935\/1414-8145.20130021","article-title":"Self-care for the treatment of leg ulcers in sickle cell anemia: nursing guidelines","volume":"17","author":"Martins","year":"2013","journal-title":"Esc Anna Nery"},{"key":"10.1016\/j.hemonc.2019.04.002_b0090","unstructured":"Carneiro JS, Gon\u00e7alves M de S, Albuquerque SRL, Fraiji NA, Neto JP de M. Sickle cell disease patients from the occidental Brazilian 2017;2:2\u20137."},{"issue":"5","key":"10.1016\/j.hemonc.2019.04.002_b0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hemonc.2019.04.002_b0100","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2006-01-011072","article-title":"Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia","volume":"108","author":"Boyd","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hemonc.2019.04.002_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/ehm.11.61","article-title":"The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease","volume":"4","author":"Strouse","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.hemonc.2019.04.002_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2006.07.003","article-title":"The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon","volume":"250","author":"Njamnshi","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.hemonc.2019.04.002_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcmd.2015.01.011","article-title":"Severity of Brazilian sickle cell disease patients: Severity scores and feasibility of the Bayesian network model use","volume":"54","author":"Belini Junior","year":"2015","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.hemonc.2019.04.002_b0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-041817-125507","article-title":"Emerging genetic therapy for sickle cell disease","volume":"70","author":"Orkin","year":"2019","journal-title":"Annu Rev Med"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387619300408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387619300408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2019.04.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:49:15Z","timestamp":1787838555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2019.04.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2019.04.002","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}